Roger Hajjar

Dr. Roger J.
Hajjar, MD, is an Independent Director at Longeveron, Inc., a Director-Gene & Cell Therapy at Mass General Brigham, Inc., a President, Director & Chief Medical Officer at Medera, Inc., a Chief Executive Officer at Sardocor Corp., a Head-Research & Development at Ring Therapeutics, Inc. and a President, Chief Medical Officer & Director at Medera, Inc. /New/.
He is on the Board of Directors at Longeveron, Inc., Atamyo Therapeutics SAS, Medera, Inc. and Medera, Inc. /New/.
Dr. Hajjar was previously employed as a Director-Cardiovascular Research Center by Icahn School of Medicine at Mount Sinai and a Director-Cardiovascular Research by Celladon Corp.
He also served on the board at Cellectis SA. He received his undergraduate degree from The Johns Hopkins University and a doctorate degree from Harvard Medical School.